share_log

花旗:下调Calliditas Therapeutics(CALT.US)评级,由买入调整至中性评级, 目标价39.00美元。

Zhitong Finance ·  May 31 15:45

花旗:下调Calliditas Therapeutics(CALT.US)评级,由买入调整至中性评级, 目标价39.00美元。

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment